da Costa Rodrigo Cordovil Pinto Lobo, Rodrigues Ana Clara Tude, Vieira Marcelo Luiz Campos, Fischer Claudio Henrique, Monaco Claudia Gianini, Filho Edgar Bezerra Lira, Bacal Fernando, Caixeta Adriano, Morhy Samira Saady
Hospital Israelita Albert Einstein, São Paulo, Brazil.
Front Cardiovasc Med. 2022 Oct 13;9:991016. doi: 10.3389/fcvm.2022.991016. eCollection 2022.
Heart transplantation represents main therapy for end-stage heart failure. However, survival after transplantation is limited by development of graft rejection. Endomyocardial biopsy, an invasive and expensive procedure, is gold standard technique for diagnosis of rejection. Most of biopsy complications are observed using echocardiography. Novel echocardiographic techniques, such as myocardial strain and three-dimensional reconstruction, can be useful in heart transplant patients.
To evaluate ventricular strain in heart transplant patients and association with rejection, cellular or humoral, as well as two- and three-dimensional echocardiographic parameters.
Cohort of patients from heart transplant program taken to echocardiography after endomyocardial biopsy, from December 2017 to January 2020. Ventricular strain and three-dimensional left ventricle parameters were studied. Rejection results were retrieved from medical record. Qualitative variables were expressed by absolute frequency and percentages, while continuous variables by means and standard deviations. Association between rejection and variables of interest was measured by odds ratio and confidence interval of 95%, with -value < 0.05.
123 post-endomyocardial biopsy echocardiographic exams were performed in 54 patients. Eighteen exams were excluded, lasting 105 exams to be evaluated for conventional and advanced echocardiographic parameters. Male patients were 60.4%. Prevalence of cellular rejection was 8.6%, humoral rejection 12.4%, and rejection of any type 20%. There was no association between right ventricular strain and rejection, whether cellular ( = 0.118 and = 0.227 for septum and free wall, respectively), humoral ( = 0.845 and = 0.283, respectively), or of any type (0.504 and 0.446). There was no correlation between rejection and left ventricle global longitudinal strain, three-dimensional ejection fraction or desynchrony index. Conventional parameters associated to rejection were left ventricle posterior wall thickness [OR 1.660 (1.163; 2.370), = 0.005] and left ventricle mass index [OR 1.027 (1.011; 1.139), = 0.001]. Left ventricle posterior wall thickness remained significant after analysis of cellular and humoral rejection separately [OR 1.825 (1.097; 3.036), = 0.021 and OR 1.650 (1.028; 2.648), = 0.038, respectively].
There was no association between ventricular strain, three-dimensional left ventricular ejection fraction and the desynchrony index and rejection, cellular or humoral. Evidence of association of graft rejection with left ventricle posterior wall thickness and left ventricle mass index was observed.
心脏移植是终末期心力衰竭的主要治疗方法。然而,移植后的生存受到移植物排斥反应发展的限制。心内膜心肌活检是一种侵入性且昂贵的检查,是诊断排斥反应的金标准技术。大多数活检并发症可通过超声心动图观察到。新型超声心动图技术,如心肌应变和三维重建,可能对心脏移植患者有用。
评估心脏移植患者的心室应变及其与细胞性或体液性排斥反应以及二维和三维超声心动图参数的相关性。
对2017年12月至2020年1月期间接受心内膜心肌活检后进行超声心动图检查的心脏移植项目患者队列进行研究。研究心室应变和三维左心室参数。从病历中获取排斥反应结果。定性变量用绝对频率和百分比表示,连续变量用均值和标准差表示。通过比值比和95%置信区间测量排斥反应与感兴趣变量之间的关联,P值<0.05。
54例患者共进行了123次心内膜心肌活检后的超声心动图检查。排除18次检查,剩余105次检查用于评估传统和先进的超声心动图参数。男性患者占60.4%。细胞性排斥反应的患病率为8.6%,体液性排斥反应为12.4%,任何类型的排斥反应为20%。右心室应变与排斥反应之间无关联,无论是细胞性排斥反应(间隔和游离壁的P值分别为0.118和0.227)、体液性排斥反应(分别为0.845和0.283)还是任何类型的排斥反应(0.504和0.446)。排斥反应与左心室整体纵向应变、三维射血分数或不同步指数之间无相关性。与排斥反应相关的传统参数是左心室后壁厚度[比值比1.660(1.163;2.370),P = 0.005]和左心室质量指数[比值比1.027(1.011;1.139),P = 0.001]。分别分析细胞性和体液性排斥反应后,左心室后壁厚度仍具有显著性[比值比分别为1.825(1.097;3.036),P = 0.021和1.650(1.028;2.648),P = 0.038]。
心室应变、三维左心室射血分数和不同步指数与细胞性或体液性排斥反应之间无关联。观察到移植物排斥反应与左心室后壁厚度和左心室质量指数之间存在关联的证据。